SDZNY:OTCMKTS
SANDOZ GROUP ADR
$99.56
arrow_downward
-1.18%(-1.19) 1D
Oct 30, 1:47:56 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZNY...
Open
$101.43
High
$101.62
Low
$99.56
Mkt. cap
36.09B
Avg. vol.
25.78K
Volume
37.69K
52-wk high
$103.22
52-wk low
$65.31
Shares outstanding
440.00M
No. of employees
20K
Open
$101.43
High
$101.62
Low
$99.56
Mkt. cap
36.09B
Avg. vol.
25.78K
Volume
37.69K
52-wk high
$103.22
52-wk low
$65.31
Shares outstanding
440.00M
No. of employees
20K
News stories
From web sources and news partners
marketscreener.com
·
1 day ago
Sandoz Group AG Revised Earnings Guidance for the Full Year 2026
Reuters
·
2 days ago
Generic drugmaker Sandoz cuts sales outlook, shares fall
Investing.com
·
2 days ago
Earnings call transcript: Sandoz narrows 2026 sales view after strong Q3
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About SANDOZ GROUP ADR